Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.01%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 99.50
OMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, Director Dealing and TVR

4 Jul 2022 17:53

RNS Number : 2755R
Oxford Metrics PLC
04 July 2022
 

4 July 2022

Oxford Metrics plc

("Oxford Metrics" or the "Company")

Exercise of Options, Director Dealing and Total Voting Rights

Oxford Metrics plc (AIM:OMG), the smart sensing software company servicing, life sciences, entertainment and engineering markets, announces that, on 4 July 2022, it issued 2,200,000 new ordinary shares of 0.25 pence each in the Company following an exercise of options pursuant to the Company's share option schemes to certain Directors of the Company; Nicholas Bolton (Chief Executive Officer), David Deacon (Chief Financial Officer) and Catherine Robertson (Executive Director) (together the "Exercising PDMRs").

The Exercising PDMRs have exercised, in aggregate, options over 2,200,000 shares and have sold 928,212 shares to cover the exercise cost and personal tax liabilities arising from the exercise.

Following the dealings described above, the Exercising PDMRs beneficial interests in the Company are set out below:

Director / PDMR

Current holding of Shares

Options exercised

Shares sold to cover exercise cost and tax liabilities

New holding of Shares

% of total voting rights in the Company(1)

 

 

Nicholas Bolton

2,383,565

1,200,000

513,002

3,070,563

2.41%

David Deacon

1,146,821

600,000

179,026

1,567,795

1.23%

Catherine Robertson

1,439,201

400,000

236,184

1,603,017

1.26%

(1) Total Voting Rights of 127,415,890 as at 24 June 2022

Pursuant to the exercise of these share options, the Company confirms that application has been made to the London Stock Exchange for the admission of 2,200,000 Ordinary Shares to trading on AIM. Admission is expected to take place at 8.00am on 11 July 2022.

Total Voting Rights

Following Admission, the Company will have 129,615,890 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 129,615,890.

Oxford Metrics

Nick Bolton, CEO

David Deacon, CFO

 

+44 (0) 1865 261800

Numis Securities Limited

Simon Willis

Hugo Rubinstein

Tejas Padalkar

 

+44 (0)20 7260 1000

FTI Consulting

Matt Dixon / Jamille Smith / Jemima Gurney

 +44 (0) 20 3727 1000

 

About Oxford Metrics

 

Oxford Metrics develops software that enables the interface between the real world and its virtual twin. Our smart sensing software helps over 10,000 customers in more than 70 countries, including all of the world's top 10 games companies and all of the top 20 universities worldwide. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, then moved into defence and engineering. We have a track record of creating value by incubating, growing and then augmenting through acquisition, unique technology businesses.

 

The Group trades through its market-leading division: Vicon. Vicon is a world leader in motion measurement analysis to thousands of customers worldwide, including Guy's Hospital, Industrial Light & Magic, MIT and NASA.

 

The Group is headquartered in Oxford with offices in California, Colorado, and Auckland. Since 2001, Oxford Metrics (LSE: OMG), has been a quoted company listed on AIM, a market operated by the London Stock Exchange. For more information about Oxford Metrics, visit www.oxfordmetrics.com

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Nicholas Bolton

2. David Deacon

3. Catherine Robertson

2

Reason for the notification

a)

Position/status

1. PDMR - Chief Executive Officer

2. PDMR - Chief Financial Officer

3. PDMR - Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Metrics Plc

b)

LEI

2138002ZKGRM1MQ8JW43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 0.25p shares

ISIN: GB0030312788

b)

Nature of the transaction

Issue of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Exercise price: 0.25 pence per Ordinary Share

2. Exercise price: 0.25 pence per Ordinary Share

3. Exercise price: 59.06 pence per Ordinary Share

1. 1,200,000 Ordinary Shares

2. 600,000 Ordinary Shares

3. 400,000 Ordinary Shares

d)

Aggregated information

N/a (Single transaction)

e)

Date of the transaction

4 July 2022

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Nicholas Bolton

2. David Deacon

3. Catherine Robertson

2

Reason for the notification

a)

Position/status

1. PDMR - Chief Executive Officer

2. PDMR - Chief Financial Officer

3. PDMR - Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Metrics Plc

b)

LEI

2138002ZKGRM1MQ8JW43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 0.25p shares

ISIN: GB0030312788

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. 102 pence per Ordinary Share

2. 102 pence per Ordinary Share

3. 102 pence per Ordinary Share

1. 513,002 Ordinary Shares

2. 179,026 Ordinary Shares

3. 236,184 Ordinary Shares

d)

Aggregated information

N/a (Single transaction)

e)

Date of the transaction

4 July 2022

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSUFMLEESELW
Date   Source Headline
23rd Oct 20087:00 amRNSTrading Update
30th Sep 20082:29 pmRNSTotal Voting Rights
3rd Sep 20087:00 amRNS2d3 secures landmark contract
24th Jul 20081:18 pmRNSDirector/PDMR Shareholding
24th Jul 20081:10 pmRNSDirector/PDMR Shareholding
21st Jul 20087:00 amRNSSpringboard Contract Win
16th Jul 20083:33 pmRNSExercise of Options
14th Jul 20087:00 amRNSAppointment of FD
14th Jul 20087:00 amRNSDirectorate Change
10th Jul 20087:00 amRNSAnalyst & Investor Day
8th Jul 20085:22 pmRNSExercise of options
30th Jun 20082:28 pmRNSExercise of Options
17th Jun 20087:00 amRNSInterim Results
13th Jun 20087:00 amRNSContract Win
4th Jun 20084:27 pmRNSExercise of Options
3rd Jun 20087:00 amRNSVicon Product Launch
28th Apr 20087:00 amRNSAcquisition
22nd Apr 20087:00 amRNSTrading Update
31st Mar 20082:17 pmRNSDirector/PDMR Shareholding
12th Mar 20087:00 amRNSYotta DCL Contracts
27th Feb 20084:00 pmRNSAGM Statement
31st Dec 200711:13 amRNSTotal Voting Rights Update
18th Dec 20077:02 amRNSContract Win
12th Dec 20071:13 pmRNSDirector/PDMR Shareholding
11th Dec 20071:32 pmRNSDirector/PDMR Shareholding
10th Dec 20077:01 amRNSYotta DCL Contract Win
6th Dec 20072:57 pmRNSHolding(s) in Company
28th Nov 20077:01 amRNSFinal Results
8th Nov 20071:22 pmRNSHolding(s) in Company
1st Nov 20077:01 amRNSTrading Update
31st Aug 200710:54 amRNSDirector/PDMR Shareholding
28th Aug 20077:02 amRNSContract Win
22nd Aug 20075:29 pmRNSDirector/PDMR Shareholding
17th Aug 200712:06 pmRNSAIM Rule 26 - Company Website
31st Jul 20077:01 amRNSContract Win
26th Jul 20077:00 amRNSAcquisition
5th Jul 200710:45 amRNSTotal Voting Rights Update
28th Jun 200710:06 amRNSAdditional Listing
22nd Jun 20072:42 pmRNSAdditional Listing
18th Jun 20073:22 pmRNSAdditional Listing
13th Jun 20077:01 amRNSInterim Results
10th May 20077:01 amRNSGSV Contract Wins
27th Apr 20077:01 amRNSTrading Update
11th Apr 20077:02 amRNSProduct Launch
22nd Mar 20073:10 pmRNSHolding(s) in Company
21st Mar 20073:02 pmRNSHolding(s) in Company
9th Mar 20075:15 pmRNSReport & Accounts
16th Feb 20074:00 pmRNSAGM Statement
2nd Feb 20077:00 amRNSGSV Contract Win
3rd Jan 20073:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.